- Home
- NMHI vs SLXN Comparison
NMHI vs SLXN Comparison
Compare NMHI & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMHI
- SLXN
- Stock Information
- Founded
- NMHI N/A
- SLXN 2008
- Country
- NMHI United States
- SLXN Israel
- Employees
- NMHI N/A
- SLXN N/A
- Industry
- NMHI
- SLXN
- Sector
- NMHI
- SLXN
- Exchange
- NMHI NYSE
- SLXN NYSE
- Market Cap
- NMHI 2.7M
- SLXN 3.0M
- IPO Year
- NMHI N/A
- SLXN N/A
- Fundamental
- Price
- NMHI $0.10
- SLXN $0.21
- Analyst Decision
- NMHI
- SLXN Strong Buy
- Analyst Count
- NMHI 0
- SLXN 1
- Target Price
- NMHI N/A
- SLXN $1.00
- AVG Volume (30 Days)
- NMHI 100.2M
- SLXN 1.5M
- Earning Date
- NMHI 11-14-2024
- SLXN 11-14-2024
- Dividend Yield
- NMHI N/A
- SLXN N/A
- EPS Growth
- NMHI N/A
- SLXN N/A
- EPS
- NMHI N/A
- SLXN N/A
- Revenue
- NMHI $9,994,275.00
- SLXN N/A
- Revenue This Year
- NMHI N/A
- SLXN N/A
- Revenue Next Year
- NMHI N/A
- SLXN N/A
- P/E Ratio
- NMHI N/A
- SLXN N/A
- Revenue Growth
- NMHI N/A
- SLXN N/A
- 52 Week Low
- NMHI $0.08
- SLXN $0.21
- 52 Week High
- NMHI $11.40
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- NMHI 43.37
- SLXN N/A
- Support Level
- NMHI $0.08
- SLXN N/A
- Resistance Level
- NMHI $0.23
- SLXN N/A
- Average True Range (ATR)
- NMHI 0.05
- SLXN 0.00
- MACD
- NMHI 0.00
- SLXN 0.00
- Stochastic Oscillator
- NMHI 4.94
- SLXN 0.00
About NMHI NATURES MIRACLE HLDG INC
Nature's Miracle Holding Inc is a growing agriculture technology company providing Controlled Environment Agriculture (CEA) hardware products to growers in the CEA industry setting in North America. It provides hardware to design, build, and operate various indoor growing settings, including greenhouse and indoor growing spaces. Its products include Horticultural Lighting, Irrigation System, Power Distribution Systems, Climate Control Systems, Disinfection Systems, and Materials And Equipment.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.